Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330967 · ClinicalTrials.gov registry record
Mechanisms of Insulin Resistance in Humans
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 25
- Enrollment target
NCT00330967 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 25 participants.
The verdict
NCT00330967 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The Objectives of the study are to: (1)compare the inflammatory response and insulin resistance in skeletal muscles during a systemic infusion of lipid with that during a local infusion of lipid into the femoral artery. which would cause minimal or no systemic hyperlipidemia but local plasma free fatty acid (FFA) concentrations similar to those during the systemic lipid infusion, and (2) determine the inflammatory response and insulin resistance in skeletal muscle during an infusion of lipid into the femoral artery as described above after NF-KB inhibition by high dose salicylate treatment in humans.
Interventions
- DRUG 20% Intralipid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-04 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330967
The ClinicalTrials.gov registry entry for NCT00330967 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 20% Intralipid is the first listed.
NCT00330967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330967 about?
NCT00330967 is a clinical study titled "Mechanisms of Insulin Resistance in Humans". The Objectives of the study are to: (1)compare the inflammatory response and insulin resistance in skeletal muscles during a systemic infusion of lipid with that during a local infusion of lipid into the femoral artery. which would cause minimal or no systemic hyperlipidemia but local plasma free fa...
What is the current status of trial NCT00330967?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-04. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00330967?
The interventions under investigation include: 20% Intralipid (DRUG).
Who is sponsoring clinical trial NCT00330967?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.